Laser Images Inc

Applied Technologies Group (ATG) is a distinguished government service provider based in Huntsville, Alabama, with additional operations in California, Maryland. The company is known for its commitment to quality service, driven by a knowledgeable team and a focus on customer needs. ATG offers a diverse range of services, including logistics, technical engineering, programmatic support, and cybersecurity. With an emphasis on innovative concepts and sound management principles, the company strives to enhance operational efficiency and deliver quality personnel to its customers and strategic partners. Generated from the website

Quantum Research International, established in 1987, in Huntsville, Ala., is a small business that provides planning, research and analysis and engineering and information technology products, services and solutions to the United States Armed Forces, federal government and industry customers. The company s core competencies include force modernization, military systems support, information operations, architecture development and analysis, survivability analysis and assessment, test and evaluation, air space and missile defense, modeling and simulation, organizational assessments, team building, business process reengineering, systems engineering and integration and logistics. Quantum also has personnel located onsite at the Pentagon; Missile Defense Agency; Fort Belvoir and Fort Monroe, Va.; Fort Bliss, Fort Hood and Fort Sam Houston, Texas; Fort Gillem, Fort Gordon, Fort McPherson, Fort Stewart and Warner Robins AFB, Ga.; Schofield Barracks and Fort Shafter, Hawaii; Fort Bragg, N.C.; Fort Campbell, Ky.; Fort Carson, Colo.; Fort Drum, N.Y.; Fort Huachuca, Ariz.; Fort Indiantown Gap, Pa.; Fort Richardson, Ark.; and Germany.

Serina Therapeutics, Inc., based in Huntsville, AL, is at the forefront of developing innovative drug delivery technologies through its proprietary POZ platform. This platform enables programmable targeted delivery of small molecules and has demonstrated safety and efficacy through continuous drug delivery via a once-weekly subcutaneous injection. The company has a robust pipeline of small molecule and RNA vaccine candidates designed to address significant unmet medical needs, particularly in central nervous system (CNS) disorders and oncology. Through strategic collaborations, Serina is advancing lipid nanoparticle-based drug delivery systems in mRNA immunology and optimizing antibody-drug conjugates to potentially enhance cancer treatment outcomes. Generated from the website